Current Research

Research for T-cell leukemia is ongoing. The following treatments may still be under investigation in clinical trials and may not be approved or available at this time. Always discuss all diagnostic and treatment options with your doctor.

New therapies are being tested in clinical trials, including new combinations of chemotherapy and biologic therapies, which use the body’s immune system to fight cancer.  For ATLL, several new therapies are being explored including bortezomib (Velcade); arsenic trioxide (Trisenox); and daclizumab (Zenapax), an anti-IL2 antibody.